Kato J, Sherr C J
Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
Oncogene. 1991 May;6(5):687-93.
A nontransformed revertant subclone (GVR17) was isolated from mutagen-treated populations of mink epithelial cells which had been transformed by the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The revertant cells, although contact-inhibited for growth and unable to form colonies in semisolid medium, contained two copies of integrated SM-FeSV proviral DNA, expressed high levels of the v-fms oncogene product and its associated tyrosine kinase activity, and yielded rescuable viruses able to transform parental mink epithelial and mouse NIH3T3 cells. The transformed phenotype was suppressed in cell hybrids generated by fusing revertant and v-fms-transformed mink cells, indicating that GVR17 cells harbored a dominant cellular mutation that inhibited transformation by the v-fms oncogene. The revertant cells were refractory to retransformation by retroviruses containing v-fms or v-abl oncogenes, but could be transformed by v-ras-, v-raf-, and v-fes-containing retroviruses. Thus, the suppressing activity in GVR17 cells discriminates between transforming signals mediated by different tyrosine kinases and fails to block the transforming activity of two oncoproteins exhibiting either GTP-binding or serine/threonine kinase activity.
从经诱变处理的貂上皮细胞群体中分离出一个未转化的回复子亚克隆(GVR17),该细胞群体已被猫肉瘤病毒苏珊·麦克多诺株(SM-FeSV)转化。回复子细胞虽然生长受到接触抑制且无法在半固体培养基中形成集落,但含有两份整合的SM-FeSV前病毒DNA,表达高水平的v-fms癌基因产物及其相关的酪氨酸激酶活性,并产生能够转化亲代貂上皮细胞和小鼠NIH3T3细胞的可拯救病毒。通过融合回复子细胞和v-fms转化的貂细胞产生的细胞杂种中,转化表型受到抑制,这表明GVR17细胞携带一种显性细胞突变,该突变抑制了v-fms癌基因的转化作用。回复子细胞对含有v-fms或v-abl癌基因的逆转录病毒的再转化具有抗性,但可被含有v-ras、v-raf和v-fes的逆转录病毒转化。因此,GVR17细胞中的抑制活性能够区分由不同酪氨酸激酶介导的转化信号,并且不能阻断表现出GTP结合或丝氨酸/苏氨酸激酶活性的两种癌蛋白的转化活性。